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Genetic elements associated with antimicrobial
resistance in enteropathogenic Escherichia coli
(EPEC) from Brazil
Isabel CA Scaletsky1*, Tamara B Souza2, Katia RS Aranda1, Iruka N Okeke3
Abstract
Background: We recently observed an association of resistance with a certain enteropathogenic Escherichia coli
(EPEC) serotypes and identified a conjugative plasmid, similar to plasmid pED208, that was conserved among
archival O111:H2/NM and O119:H2 strains of diverse geographical origin. In this study, we sought to determine the
prevalence and distribution of this plasmid among a collection of EPEC isolates from Brazil, as well as to study the
susceptibilities of these isolates to antimicrobial agents.
Results: Resistance was more commonly seen in typical EPEC than atypical strains. The most prevalent resistances
were to ampicillin, tetracycline, streptomycin and the sulfonamides. Markers for the EPEC conjugative
multiresistance plasmid, were detected in 21 (30%) of typical but only 4 (5%) of atypical strains (p = 0.001, Chi-
squared test). This plasmid, previously reported from only O111 and O119 strains was found in O55 and O127
strains and was associated with the presence of class 1 integrons.
Conclusion: Our data suggest a limited but expanding host range for the EPEC resistance plasmid.
Background
Enteropathogenic Escherichia coli (EPEC) is an impor-
tant cause of infantile diarrhea worldwide and particu-
larly in developing countries [1,2]. EPEC strains adhere
intimately to the brush border of the intestinal epithe-
lium and initiate a complex signaling cascade by virtue
of a chromosomal pathogenicity island, the locus for
enterocyte effacement (LEE) (reviewed by Clarke et al
[3]). EPEC strains also carry an EPEC adherence factor
(EAF) plasmid, which encodes the bundle forming pili, a
plasmid-encoded regulator, and other putative virulence
genes. The majority of EPEC isolates belong to classic
serotypes derived from 12 classical O serogroups (O26,
O55, O86, O111, O114, O119, O125, O126, O127,
O128, O142, and O158) [4,5]. A robust genetic defini-
tion, and molecular and cellular detection methods,
have made it possible to expand the repertoire of known
EPEC lineages, identifying other EPEC that possess the
LEE but do not harbor the EAF plasmid [5,6]. Thus,
EPEC strains harboring the EAF plasmid are classified
as “typical EPEC”, while strains which do not harbor the
EAF plasmid, are classified as atypical EPEC” [7].
For many decades, typical EPEC was the main bacter-
ial enteropathogen in infants in Brazil. Several studies in
the 1980s and early 1990s showed a high frequency of
typical serotypes, particularly serotypes O111:H2 and
O119:H6 [2,8-16]. However, some recent studies have
shown a decrease in the isolation rates of these sero-
types accompanied by and an apparent increase in the
frequency of atypical EPEC [9,10,17-20]. Most atypical
EPEC strains belong to traditional EPEC serogroups, but
several strains of non-EPEC serogroups have also been
identified in different epidemiological studies
[9,10,17,21].
Although most EPEC infections resolve without anti-
microbial therapy, antimicrobials should be administered
in persistent infections, where the choice of effective
antimicrobials may be crucial for patient recovery and
even survival [22]. In addition to a selective pressure,
specifically directed towards EPEC, the persistence of
resistant EPEC strains is even more likely to be related
to selective pressure from antimicrobials applied at the
population level. There is considerable evidence to
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suggest that young children, those most vulnerable to
EPEC infection, are at risk of infection with resistant
commensals, as well as pathogens, from their caregivers
and household contents [23,24]. Therefore resistance
genes acquired and recombined in other niches may
present in EPEC strains from infants.
Many isolated enteric bacterial are known to harbor
mobile elements that encode antimicrobial resistance.
For example, apparently successful conserved elements
have recently been described in Salmonella serovars and
Yersiniae [25,26]. We recently observed an association
of resistance with a certain EPEC serotypes and identi-
fied a conjugative plasmid, similar to plasmid pED208,
that was conserved among archival O111:H2/NM and
O119:H2 strains of diverse geographical origin [27].
However the distribution and therefore significance of
this element is yet to be studied more broadly, particu-
larly in recent isolates. In this study, we sought to deter-
mine the prevalence and distribution of this plasmid
among a collection of EPEC isolates from Brazil, as well
as to study the susceptibilities of these isolates to anti-
microbial agents.
Results and Discussion
We assessed resistance in 149 EPEC strains (70 typical
and 79 atypical) isolated from Brazilian children in pre-
viously described studies [9,10,21]. Typical EPEC isolates
were commonly resistant to ampicillin, tetracycline,
streptomycin and the sulfonamides (Table 1). All but 14
(20%) typical strains were resistant to at least one anti-
microbial and 30 (43%) of the strains were resistant to
three or more of the antimicrobials tested. Atypical
EPEC strains were much less likely to be resistant to
ampicillin, tetracycline, streptomycin and the sulfona-
mides, but were more likely to show resistance to tri-
methoprim. Although resistance to quinolones and
extended-spectrum beta-lactams has emerged among
enteric organisms, all the strains tested in this study
were susceptible to these drugs.
EPEC strains bearing the recently reported resistance
plasmid, which we sought in this study, carry at least
two, and sometimes more than three, large plasmids
[27]. Additionally, because the plasmid is only partially
conserved, plasmid profiling cannot be used to study its
distribution. Instead, we used primers that recognize
traI and traC genes from the conjugative transfer region
of this resistance plasmid, and the closely related plas-
mid pED208, to screen the recent Brazilian EPEC iso-
lates for the presence of this element by PCR [27]. We
have previously demonstrated that these primers do not
produce amplicons with other known conjugative plas-
mids, other than those related to pED208 [27]. We addi-
tionally screened the strains for a trbC-traU region that
is present in pED208 but absent from the EPEC
multiresistant plasmid. All the strains screened in this
study failed to produce an amplicon with this primer
pair.
As shown in Table 2, both the traI and the traC
amplicons were produced in 21 (30%) of typical but
only 4 (5%) of atypical strains (p = 0.001, Chi-squared
test). Moreover, 18 (26%) typical EPEC but only 5 (6%)
atypical EPEC produced an amplicon with at least one
of the primers pairs (p = 0.001). Of the 9 atypical EPEC
that possessed the traI and/or traC marker, four
belonged to O55 or O119 serogroups, which are asso-
ciated with typical EPEC (see Additional file 1). These
strains were negative for EAF and bfpA probes, but they
were positive for perA, an EAF gene [21]. Therefore, like
some other atypical strains that have been described in
the literature [28-30], these strains carry vestiges of the
EAF plasmid.
Our data show that the EPEC resistance plasmid is
found commonly in typical EPEC, and is uncommon in
atypical EPEC, consistent with earlier data [27]. How-
ever, previous evaluation of the distribution of the EPEC
multiresistance plasmid in a small collection of archival
strains suggested that it was limited to O111:H2 and
O119:H2 strains, which carry the EAF plasmid or ves-
tiges of it [27]. In the current study, traI and traC mar-
kers from the resistance plasmid were identified in
strains belonging to the serotypes O55:H6, O127:H6,
and O119:H6, as well as O55 and O119 atypical strains
that carry vestiges of the EAF plasmid (see Additional
file 1). To determine whether this broader distribution
among Brazilian isolates was a recent development, we
screened 36 archival EPEC strains that were isolated in
the 1970s and 1980s from children with diarrhea in São
Table 1 Antimicrobial resistance of EPEC isolates from
Brazil
Antimicrobial N° (%) of resistant EPEC isolates:
tEPEC
(n = 70)
aEPEC
(n = 79)
Ampicillin 42 (60) 19 (24)
Chloramphenicol 14 (20) 2 (2.5)
Kanamycin 0 0
Sulphonamide 44 (62.8) 20 (25.3)
Streptomycin 24 (34.3) 8 (10.1)
Tetracycline 30 (42.8) 8 (10.1)
Trimethoprim 1 (1.4) 13 (16.4)
Ceftazidime 0 0
Ciprofloxacin 0 0
Lomefloxacin 0 0
Ofloxacin 0 0
Nalidixic acid 0 0
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Paulo [12], and the plasmid was predominately found in
O111:H2, O119:H6 and O142:H6 strains (data not
shown), which were among the most common circulat-
ing serovars at that time [2,13,31].
Although isolates that were susceptible to all tested
agents were more likely to be traI and traC negative and
strains that had these markers were to a higher degree
multiple resistant, in contrast to the association seen
with older isolates from other geographic locations [27],
we did not find that the presence of traI and traC mar-
kers in the EPEC isolates were absolutely or significantly
associated with multiple resistance. The EPEC resistance
plasmids of previously studied O111 and O119 strains
bear class 1 integrons as well as one or more resistance
genes identical to those on Salmonella enterica subsp.
Typhi multiresistant plasmid pHCM1 [25]. Some typical
strains and all atypical strains had fewer of these markers,
even though antimicrobial resistance was just as common
in these isolates (see Additional file 1). Among isolates 12
of 39 strains carrying the EPEC resistance plasmid and
one of 31 strains without it had a class 1 integron (p =
0.0025, Yates corrected Chi-squared test). None of the
other markers screened showed significant association
with the plasmid in strains. Combined with the resistance
data, these findings suggest that the EPEC resistance
plasmid plays less of a role in conferring resistance in
these EPEC isolates, in particular atypical strains, and
that there may be possible other genetic elements confer-
ring resistance among those strains.
EPEC strains bearing the EPEC resistance plasmid
carry at least two, and sometimes more than three, large
plasmids [27,30]. We used a PCR-based replicon typing
scheme to determine other possible plasmid types con-
ferring antimicrobial resistance in the EPEC strains stu-
died. Our results indicate that both typical and atypical
strains harbor plasmid types which have been shown to
carry mobile genetic elements encoding drug-resistance.
In addition, significant differences in plasmid replicon
content were observed between typical and atypical
EPEC strains (Table 2). In particularly, the IncI1 repli-
con occurred significantly more often among typical
strains, whereas the IncFrep replicon was observed sig-
nificantly more often among atypical strains (p = 0.013
and p = 0.001, respectively) The IncT, IncFIIA, IncFIA,
IncX, IncHI1, IncN, IncHI2, and IncL/M replicons were
not detected in any of the strains. Among the replicon
profiles identified, IncFIB occurring alone was the most
common (see Additional file 1).
Antimicrobial resistance is increasing worldwide. Resis-
tance in intestinal organisms is of interest it can compro-
mise treatment of infections caused by pathogenic strains
but also because the gut is a complex, diverse and heavily
populated niche and resistant organisms there can trans-
mit resistance genes horizontally. Many investigators
have documented a high prevalence of antimicrobial
resistance among EPEC strains in different parts of the
world but few of these studies have been performed on
recent isolates [22,32-35]. Resistance appeared at the
beginning of the antibiotic era and epidemiological data
suggests that its prevalence is associated with the 1970s
and 1980s and diversity of antimicrobial use [33,35]. The
genetic basis for this resistance and the evolutionary con-
sequences are rarely studied.
Conclusion
Our data show that the EPEC resistance plasmid is
found commonly in typical EPEC, and is uncommon in
Table 2 Occurrence of EPEC conjugative multiresistance
plasmid loci and plasmid replicons among EPEC isolates
from Brazil
Gene or Replicon No. (%) of isolates positive:
tEPEC
(n = 70)
aEPEC
(n = 79)
Conjugative genes
traI 11 (15.7) 3 (3.8)
traC 7 (10) 2 (2.5)
traI+traC 21 (30) 4 (5.1)
Class 1 integrons
aadA1 12 (17.1) 1 (1.3)
sulII 25 (35.7) 3 (3.8)
tetA 14 (20) 0
Cat 13 (18.6) 1 (1.3)
merA 3 (4.3) 0
Replicons
B/O 1 (1.4) 1 (1.3)
FIC 0 1 (1.3)
A/C 1 (1.4) 3 (3.8)
P 1 (1.4) 0
T 0 0
K/B 11 (15.7) 15 (18.9)
W 3 (4.3) 21 (26.6)
FHA 0 0
FIA 0 0
FIB 32 (45.7) 23 (29.1)
Y 0 1 (1.3)
I1 11 (15.7) 3 (3.8)
Frep 1 (1.4) 17 (21.5)
X 0 0
HI1 0 0
N 0 0
HI2 0 0
L/M 0 0
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atypical EPEC, consistent with earlier data. However,
previous evaluation of the distribution of the EPEC mul-
tiresistance plasmid in a small collection of archival
strains suggested that it was limited to O111:H2 and
O119:H2 strains, which carry the EAF plasmid or ves-
tiges of it. In this study, the host range of the EPEC
resistance plasmid, although still largely restricted to
typical EPEC, was seen to be greater in recent isolates.
Methods
Bacterial strains
The 149 strains examined in this report were isolated
between 1997-1999 during an epidemiological study of
acute diarrhea in children <2 years of age conducted in
different regions of Brazil and between 2002 to 2003
from children <5 years of age with diarrhea in São
Paulo [9,10,21]. These strains were identified by hybridi-
zation with eae and/or EAF probe sequences and sero-
typed. Most of these EPEC strains had also been
characterized by the presence of LEE-associated DNA
sequences, and bfpA and perA sequences, and adherence
to HEp-2 cells [21].
Preparation of bacterial DNA and PCR amplification for
detection of the EPEC conjugative multiresistance
plasmid, class 1 integron and plasmidreplicons
The bacterial DNA was extracted from a single colony
on a LB agar plate. The bacteria were suspended in 500
μl of 1X phosphate-buffered saline (pH 7.4) solution,
boiled for 10 min, and centrifuged. Two microliters of
the resulting supernatant was used as template DNA in
25 μl of the PCR mixture. Each reaction mixture con-
tained 0.4 mM deoxynucleoside triphosphates, 1 U of
Taq polymerase, 1 × Taq reaction buffer, and 2 μM of
each of the primers. Primer sequences and PCR condi-
tions used were as previously published [27]. Strains
were screened for the presence of the plasmid pMB80
by PCR using primers complementary to internal
regions of the traI and traC genes that are conserved
between the MB80 tra system and the closely related
plasmid pED208, as well as one primer pair whose pro-
duct straddles traU and trbC in pED280 in a region not
conserved in pMB80 [27]. Strains were screened for
class 1 integrons using primers designed by Levesque et
al[36] as well as for the presence of sulII gene (confer-
ring sulphonamide resistance), tetA gene (tetracycline
resistance), trimetroprim resistance gene, cat (kanamy-
cin resistance), strAB (streptomycin resistance), and a
mer operon (mercury resistance) using primers origin-
ally designed for the Salmonella enteric serovar Typhi
multiresistant plasmid, pHCM1 [25]. EPEC strains were
examined for the presence of 18 plasmid replicons using
three multiplex panels described by Johnson et al. [37].
PCR products were visualized on a 1.5% agarose gel
stained with ethidium bromide and visualized under UV
transillumination.
Antimicrobial susceptibility test
All strains were tested for their susceptibility to 12 anti-
microbial agents commonly used in Brazil [38,39] by the
broth microdilution method according to the Clinical
Laboratory Standards Institute [40]. Minimal inhibition
concentration (MIC) breakpoint levels and concentra-
tion of each antimicrobial were based on those specified
by the CLSI. Intermediately susceptible strains were
recorded as being susceptible. E. coli strain 25922
(ATCC) was used as the reference strain. All strains
were examined for resistance to ampicillin, ceftazidime,
ciprofloxacin, chloramphenicol, kanamycin, lomefloxa-
cin, ofloxacin, streptomycin, nalidixic acid, sulfonamide,
tetracycline, and trimethropin.
Additional file 1: Resistance phenotypes, markers for the EPEC
conjugative multiresistance plasmid and plamid replicons in EPEC
isolates. Antimicrobial resistance phenotypes, markers for the EPEC
conjugative multiresistance plasmid loci and plasmid replicon types in
149 EPEC (70 typical and 79 atypical) strains isolated from Brazil.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2180-10-
25-S1.DOC ]
Acknowledgements
This work was supported by Branco Weiss Fellowship to INO, Fundação de
Amparo a Pesquisa de São Paulo (Fapesp), and Conselho Nacional de
Desenvolvimento Científico e Tecnológico (CNPq). Other support currently
held by the authors includes NSF grant to INO (RUI#0516591),
Author details
1Departamento de Microbiologia, Immunologia e Parasitologia, Universidade
Federal de São Paulo, Rua Botucatu, 862, São Paulo, 04023-062, Brazil.
2Departamento de Pediatria, Universidade Federal de São Paulo, Rua
Botucatu 598, São Paulo, 04023-062, Brazil. 3Department of Biology,
Haverford College, 370 Lancaster Avenue, Haverford PA, 19041, USA.
Authors’ contributions
ICAS and INO conceived the study and wrote the paper. TBS and KRSA
performed the laboratory studies. All authors read and approved the final
manuscript.
Received: 16 April 2009
Accepted: 27 January 2010 Published: 27 January 2010
References
1. Nataro JP, Kaper JB: Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998,
11:142-201.
2. Gomes TAT, Griffin PM, Ivey C, Trabulsi LR, Ramos SRTS: EPEC infections in
Sao Paulo. Revista de Microbiologia. J Brazil Soc Microbiol 1996, 27:25-33.
3. Clarke SC, Haigh RD, Freestone PPE, Williams PH: Virulence of
enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev
2003, 16:365-378.
4. Reid S, Herbelin C, Bumbaugh A, Selander R, Whittam T: Parallel evolution
of virulence in pathogenic Escherichia coli. Nature 2000, 406:64-67.
5. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR,
Maiden MC, Ochman H, Achtman M: Sex and virulence in Escherichia coli:
an evolutionary perspective. Mol Microbiol 2006, 60:1136-1151.
6. Lacher DW, Steinsland H, Blank TE, Donnenberg MS, Whittam TS: Molecular
evolution of typical enteropathogenic Escherichia coli: Clonal analysis by
Scaletsky et al. BMC Microbiology 2010, 10:25
http://www.biomedcentral.com/1471-2180/10/25
Page 4 of 5
multilocus sequence typing and virulence gene allelic profiling. J
Bacteriol 2007, 189:342-350.
7. Trabulsi LR, Keller R, Tardelli Gomes TA: Typical and atypical
enteropathogenic Escherichia coli. Emerg Infect Dis 2002, 8:508-513.
8. Rosa AC, Mariano AT, Pereira AM, Tibana A, Gomes TA, Andrade JR:
Enteropathogenicity markers in Escherichia coli isolated from infants
with acute diarrhoea and healthy controls in Rio de Janeiro, Brazil. J Med
Microbiol 1998, 47:781-790.
9. Scaletsky ICA, Pedroso MZ, Oliva CAG, Carvalho RLB, Morais MB, Fagundes-
Neto U: A localized adherence-like pattern as a second pattern of
adherence of classic enteropathogenic Escherichia coli to HEp-2 cells
that is associated with acute infantile diarrhea. Infect Immun 1999,
67:3410-3415.
10. Scaletsky ICA, Fabbricotti SH, Silva SO, Morais MB, Fagundes-Neto U: HEp-2-
adherent Escherichia coli strains associated with acute infantile diarrhea,
São Paulo, Brazil. Emerg Infect Dis 2002, 8:855-858.
11. Campos LC, Franzolin MR, Trabulsi LR: Diarrheagenic Escherichia coli
categories among the traditional enteropathogenic E. coli O serogroups-
a review. Mem Inst Oswaldo Cruz 2004, 99:545-552.
12. Gomes TA, Vieira MA, Wachsmuth IK, Blake PA, Trabulsi LR: Serotype-
specific prevalence of Escherichia coli strains with EPEC adherence factor
genes in infants with and without diarrhea in São Paulo, Brazil. J Infect
Dis 1989, 160:131-135.
13. Magalhaes M, Amorim RJ, Takeda Y, Tsukamoto T, Antas MG, Tateno S:
Localized, diffuse, and aggregative-adhering Escherichia coli from infants
with acute diarrhea and matched-controls. Mem Inst Oswaldo Cruz 1992,
87:93-97.
14. Tsukamoto T, Takeda Y: Incidence and prevalence of serotypes of
enteroaggregative Escherichia coli from diarrheal patients in Brazil,
Myanmar and Japan. Kansenshogaku Zasshi 1993, 67:289-294.
15. Stewien KE, Mós EN, Yanaguita RM, Jerez JA, Durigon EL, Hársi CM,
Tanaka H, Moraes RM, Silva LA, Santos MA: Viral, bacterial and parasitic
pathogens associated with severe diarrhoea in the city of São Paulo,
Brazil. J Diarrhoeal Dis Res 1993, 11:148-152.
16. Gomes TA, Rassi V, MacDonald KL, Ramos SRTS, Trabulsi LR, Vieira MAM,
Guth BEC, Candeias JAN, Ivey C, Toledo MRF, Blake PA: Enteropathogens
associated with acute diarrheal disease in urban infants in São Paulo,
Brazil. J Infect Dis 1991, 164:331-337.
17. Nguyen RN, Taylor LS, Tauschek M, Robins-Browne RM: Atypical
enteropathogenic Escherichia coli infection and prolonged diarrhea in
children. Emerg Infect Dis 2006, 12:597-603.
18. Orlandi PP, Magalhães GF, Matos NB, Silva T, Penatti M, Nogueira PA,
Silva LH: Etiology of diarrheal infections in children of Porto Velho
(Rondonia, Western Amazon region, Brazil. Braz J Med Biol Res 2006,
39:507-517.
19. Afset JE, Bevanger L, Romundstad P, Bergh K: Association of atypical
enteropathogenic Escherichia coli (EPEC) with prolonged diarrhoea. J
Med Microbiol 2004, 53:1137-1144.
20. Afset JE, Bergh K, Bevanger L: High prevalence of atypical
enteropathogenic Escherichia coli (EPEC) in Norwegian children with
diarrhoea. J Med Microbiol 2003, 52:1015-1019.
21. Dulguer MV, Fabbricotti SH, Bando SY, Moreira-Filho CA, Fagundes-Neto U,
Scaletsky IC: Atypical enteropathogenic Escherichia coli strains:
phenotypic and genetic profiling reveals a strong association between
enteroaggregative E. coli heat-stable enterotoxin and diarrhea. J Infect
Dis 2003, 188:1685-1694.
22. Senerwa D, Mutanda LN, Gathuma JM, Olsvik O: Antimicrobial resistance
of enteropathogenic Escherichia coli strains from a nosocomial outbreak
in Kenya. Apmis 1991, 99:728-734.
23. Lietzau S, Raum E, von Baum H, Marre R, Brenner H: Household contacts
were key factor for children’s colonization with resistant Escherichia coli
in community setting. J Clin Epidemiol 2007, 60:1149-1155.
24. Zaidi MB, Zamora E, Diaz P, Tollefson L, Fedorka-Cray PJ, Headrick ML: Risk
factors for fecal quinolone-resistant Escherichia coli in Mexican children.
Antimicrob Agents Chemother 2003, 47:1999-2001.
25. Wain J, Diem Nga LT, Kidgell C, James K, Fortunate S, Song Diep T, Ali T,
Gaora PO, Parry C, Parkhill J, Farrar J, White NJ, Dougan G: Molecular
analysis of incHI1 antimicrobial resistance plasmids from Salmonella
serovar Typhi strains associated with typhoid fever. Antimicrob Agents
Chemother 2003, 47:2732-2739.
26. Welch TJ, Fricke WF, McDermott PF, White DG, Rosso ML, Rasko DA,
Mammel MK, Eppinger M, Rosovitz MJ, Wagner D, Rahalison L, Leclerc JE,
Hinshaw JM, Lindler LE, Cebula TA, Carniel E, Ravel J: Multiple antimicrobial
resistance in plague: an emerging public health risk. PLoS ONE 2007, 2:
e309.
27. Nwaneshiudu AI, Mucci T, Pickard DJ, Okeke IN: A second large plasmid
encodes conjugative transfer and antimicrobial resistance inO119:H2
and some typical O111 enteropathogenic Escherichia coli strains. J
Bacteriol 2007, 189:6074-6079.
28. Bortolini M, Trabulsi L, Keller R, Frankel G, Sperandio V: Lack of expression
of bundle-forming pili in some clinical isolates of enteropathogenic
Escherichia coli (EPEC) is due to a conserved large deletion in the bfp
operon. FEMS Microbiol Lett 1999, 169-174.
29. Okeke IN, Borneman JA, Shin S, Mellies JL, Quinn LE, Kaper JB: Comparative
sequence analysis of the plasmid-encoded regulator of
enteropathogenic Escherichia coli strains. Infect Immun 2001,
69:5553-5564.
30. Fernandes R, Ramos S, Rassi V, Blake P, Gomes T: Use of plasmid profiles
to differentiate strains within specific serotypes of classical
enteropathogenic Escherichia coli. Braz J Med Biol Res 1992, 25:667-672.
31. Lim YS, Ngan CC, Tay L: Enteropathogenic Escherichia coli as a cause of
diarrhoea among children in Singapore. J Trop Med Hyg 1992, 95:339-342.
32. Vila J, Vargas M, Casals C, Urassa H, Mshinda H, Schellemberg D, Gascon J:
Antimicrobial resistance of diarrheagenic Escherichia coli isolated from
children under the age of 5 years from Ifakara, Tanzania. Antimicrob
Agents Chemother 1999, 43:3022-3024.
33. Moyenuddin M, Wachsmuth IK, Moseley SL, Bopp CA, Blake PA: Serotype,
antimicrobial resistance, and adherence properties of Escherichia coli
strains associated with outbreaks of diarrheal illness in children in the
United States. J Clin Microbiol 1989, 27:2234-2239.
34. Gross RJ, Ward LR, Threlfall EJ, King H, Rowe B: Drugresistance among
infantile enteropathogenic Escherichia coli strains isolated in the United
Kingdom. Br Med J (Clin Res Ed) 1982, 285:472-473.
35. Slocombe B, Sutherland R: Transferable antibioticresistance in
enteropathogenic Escherichia coli between 1948 and 1968. Antimicrob
Agents Chemother 1973, 4:459-466.
36. Lévesque C, Piché L, Larose C, Roy PH: PCR mapping of integrons reveals
several novel combinations of resistance genes. Antimicrob Agents
Chemother 1995, 39:185-191.
37. Johnson TJ, Wannemuehler YM, Johnson SJ, Logue CM, White DG,
Doetkott C, Nolan LK: Plasmid replicon typing of commensal and
pathogenic Escherichia coli isolates. Appl Environ Microbiol 2007,
73:1976-1983.
38. Berquo LS, Barros AJ, Lima RC, Bertoldi AD: Use of drugs to treat
respiratory tract infections in the community. Rev Saude Publica 2004,
38:358-364.
39. Berquo LS, Barros AJ, Lima RC, Bertoldi AD: Use of antimicrobial drugs in
an urban population. Rev Saude Publica 2004, 38:239-246.
40. National Committee for Clinical Laboratory Standards: Performance
standards for antimicrobial disk susceptibility tests. National Committee
for Clinical Laboratory Standards, Villanova, PA, 8 2003.
doi:10.1186/1471-2180-10-25
Cite this article as: Scaletsky et al.: Genetic elements associated with
antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from
Brazil. BMC Microbiology 2010 10:25.
Scaletsky et al. BMC Microbiology 2010, 10:25
http://www.biomedcentral.com/1471-2180/10/25
Page 5 of 5
